3 completed, 1 active not recruiting, 1 unknown. 3 Phase 2, 1 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Active not recruiting 1 |
| Not applicable | 1 | Completed 1 |
| Phase 1 | 1 | Completed 1 |
Follow this drug Literature Review of Acids trials Research Report on Acids
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluate TQ-A3334 Combined Nucleoside (Acid) Analogs in the First Treatment/Treatment of Chronic HBV Infection Placebo, TQA3334 Tablet, Nucleoside (acid) analogs (NAs) - Chronic Hepatitis B | Phase 2 | Active not recruiting | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 116 | 2024-12-04 | 2026-09-11 |
| A Cohort Study on Long-term Clinical Outcomes of Antiviral Therapy in Patients With Chronic Hepatitis B and Cirrhosis interferon - Chronic Hepatitis b | Unknown | Beijing Ditan Hospital | 10000 | 2020-04-01 | 2020-03-10 | |
| Effect of Citric Acid Demineralization on Autogenous Bone Blocks Consolidation in Humans Control, Acid - Alveolar Bone Atrophy, Bone Resorption | Not applicable | Completed | University of Sao Paulo | 10 | 2017-07-01 | 2023-02-27 |
| Mechanistic Study of GSK3196165 Plus Methotrexate (MTX) in Subjects With Active Rheumatoid Arthritis GSK3196165, Placebo, MTX - Arthritis, Rheumatoid | Phase 2 | Completed | GlaxoSmithKline | 39 | 2016-06-15 | 2021-01-11 |
| αDC1 Vaccine + Chemokine Modulatory Regimen (CKM) as Adjuvant Treatment of Peritoneal Surface Malignancies DC vaccine, Celecoxib, Interferon Alfa-2b - Malignant Neoplasm of Pancreas Metastatic to Peritoneal Surface, Malignant Peritoneal Mesothelioma | Phase 1 / Phase 2 | Completed | David Bartlett | 64 | 2014-07-01 | 2020-07-20 |
Hepatitis B, Chronic (2) · Alveolar Bone Loss (1) · Arthritis, Rheumatoid (1) · Bone Resorption (1) · Carcinoma, Hepatocellular (1) · Heartburn (1) · Hepatitis B (1) · Peritoneal Neoplasms (1)
Beijing Ditan Hospital (1) · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (1) · David Bartlett (1) · GlaxoSmithKline (1) · University of Sao Paulo (1)
China (2) · United States (2) · Brazil (1) · Germany (1) · Poland (1)
2015 (1), P01CA132714 (1)